brontictuzumab (OMP-52M51) - Mereo Biopharma
OncoMed: Cantor Fitzgerald Healthcare Conference (OncoMed) - Jul 17, 2015 - Anticipated data from biomarker-selected expansion cohorts from P1a trials in advanced solid tumors (NCT01778439) and hematological malignancies (NCT01703572) in H2 2015 
Anticipated P1 data Oncology
http://wsw.com/webcast/cantor2/omed/
 
Jul 17, 2015
 
.
 
e48df7f6-7cd4-48af-94cb-18d19feb0010.jpg